The move comes less than a year after the company attempted to save $1.5 billion through the layoff of some 2,200 employees.

Welcome to the Bristol Myers Squibb fourth quarter 2024 earnings conference call. [Operator instructions] Please note this ...

Christopher Boerner; Chairman of the Board, Chief Executive Officer, Chief Operating Officer; Bristol-Myers Squibb Co David Elkins; Executive Vice President, Chief Financial Officer, Member of the ...

Q4 2024 Earnings Call Transcript February 6, 2025 Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is ...

Use of DOACs in patients with ICH and AF resulted in a remarkable reduction in ischemic stroke, but that benefit was partially offset by an increase in ICH recurrence.

Inc. (Nasdaq: TSVT) today provided full-year Abecma® (idecabtagene vicleucel; ide-cel) sales results for 2024, in partnership with Brist ...

Carrier Global Corporation ( NYSE: CARR) Q4 2024 Earnings Conference Call February 11, 2025 7:30 AM ET Michael Rednor - VP, IR David Gitlin - Chairman & CEO Patrick Goris - SVP & CFO ...

Megakaryocytes form a three-dimensional (3D) cage composed of laminin and collagen IV connected to the basement membrane surrounding them. This microarchitecture stabilizes megakaryocytes within their ...

A new report on Structure Elucidation & Verification has been released, offering insights into shifting trends and strategies ...

Analog Devices will be connecting with industry leaders in Nuremberg for Embedded World 2025. Visitors to the ADI booth will ...

Acadia Pharmaceuticals' forecasted revenues top $1bn in 2025. Find out why ACAD stock is a "Buy" with its profitable outlook ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...